
	International Journal of Pharmacology
	Year: 2011 \| Volume: 7 \| Issue: 4 \| Page No.: 516-521 DOI: 10.3923/ijp.2011.516.521

Management of Human Ulcerative Colitis by Saturex^TM: A Randomized Controlled Trial

Mansoor Rastegarpanah, Naghmeh Omidzohour, Homayoon Vahedi, Reza Malekzadeh, Farshad Hashemian, Tahereh Safarnavadeh and Mohammad Abdollahi

Abstract: To evaluate clinical benefit of Satureja Khuzestanica (SK) trade named Saturex in Ulcerative Colitis (UC). A randomized controlled trial was conducted in UC patients. Patients with proliferative retinopathy, significant renal impairment (serum creatinine>3 mg dL^-1), documented coronary artery disease, chronic liver disease, diabetic foot ulceration and gangrene and pulmonary infection were excluded from the study. The patients were administered 500 mg SK or placebo supplements once daily while they were maintained on their current treatment for UC. After 4 months, frequency difference of the disease flare up was compared between study and placebo groups. 12/14 (85.5%) of SK patients were in complete remission after 4 months as compared to 6/13 (46.2%) of the patients on placebo. The flare up frequency difference (0.07-0.73) between two groups was significant. Supplementing with SK by preventing disease flare up and keeping the patients in remission state would give the opportunity to physicians to reduce the dose of chemical drugs resulting in lower side effects and better compliance of patients.

PDF Fulltext XML References Citation Report Citation

RELATED ARTICLES:

•	An Evidence-based Review on Medicinal Plants used for the Treatment of Peptic Ulcer in Traditional Iranian Medicine

•	A Comprehensive Review of Biochemical and Molecular Evidences from Animal and Human Studies on the Role of Oxidative Stress in Aging: An Epiphenomenon or the Cause

•	Hypoglycemic Property of Satureja khuzestanica in Human Still in Doubt

•	Benefit of Lemon Verbena in Healthy Subjects; Targeting Diseases Associated with Oxidative Stress

•	An Update on Pharmacology of Satureja Species; From Antioxidant, Antimicrobial, Antidiabetes and Anti-hyperlipidemic to Reproductive Stimulation

•	An Update on Pharmacology of Satureja Species; From Antioxidant, Antimicrobial, Antidiabetes and Anti-hyperlipidemic to Reproductive Stimulation

How to cite this article:

Mansoor Rastegarpanah, Naghmeh Omidzohour, Homayoon Vahedi, Reza Malekzadeh, Farshad Hashemian, Tahereh Safarnavadeh and Mohammad Abdollahi, 2011. Management of Human Ulcerative Colitis by Saturex^TM: A Randomized Controlled Trial. International Journal of Pharmacology, 7: 516-521.

DOI: 10.3923/ijp.2011.516.521

URL: https://scialert.net/abstract/?doi=ijp.2011.516.521

COMMENT ON THIS PAPER

Navigation


		Online First
		Current Issue
		Previous Issues
		Editorial Board
		Submit a Manuscript
		Guide to Authors
		Subscribe to E-alerts

Indexed In


		ASCI-Database
		Asian Digital Library
		Chemical Abstract Services
		EMBASE
		Google Scholar
		ISI Web of Knowledge
		Science Citation Index (EXP)
		SCIMAGO
		Thomson ISI

Science Alert

Management of Human Ulcerative Colitis by SaturexTM: A Randomized Controlled Trial

Management of Human Ulcerative Colitis by Saturex^TM: A Randomized Controlled Trial